Forgot Login/Password?
Complete Story
 

2018 Annual Conference Program Descriptions

FRIDAY, April 20

8:15 a.m. (CPE Credit/Program: 0.15 CEU)

IMPROVING PATIENT OUTCOMES AND EXPANDING PHARMACY PRACTICE THROUGH POPULATION HEALTH MANAGEMENT
Kelli D. Barnes, PharmD, BCACP, Clinical Pharmacist, OSU General Internal Medicine Clinics
Pharmacists in every setting are perfectly positioned to impact population health through well-designed population health management. Population health management uses proactive, targeted interventions to improve health outcomes. This session will describe the emergence of the term population health management and outline successful pharmacist-led interventions implemented into primary care practice. Lessons learned from more than 5 years of population health management work will be summarized, as well as opportunities to advance pharmacy practice and a call to action for pharmacists to be leaders in population health management.
ACPE #0129-0000-18-015-L04-P

TIPS FOR EFFECTIVE PRECEPTING: EXPECTATIONS, EVALUATION & FEEDBACK
Experiential Education Directors, Ohio Colleges of Pharmacy
This session will focus on precepting students and residents through active learning and discussion with Ohio College of Pharmacy Experiential Directors. The session will focus on primary precepting areas of interest: tools for getting off to a successful start with learners, methods of providing feedback, evaluating learners and assisting learners in self-assessment. After activities highlighting these key elements, cases of experiential student and resident performance will be reviewed and discussed.
ACPE #0129-0000-18-016-L04-P
APPLICATION-BASED ACTIVITY

HELP OR HARM: A LOOK AT
PSYCHOTROPIC MEDICATION USE IN ADOLESCENTS
Sara Dugan, PharmD, BCPP, BCPS, Associate Professor, NEOMED
Each year in the United States between 13 and 20% of children, between the ages of 3 and 17 years, experience a mental health condition. Attention deficit hyperactivity disorder (ADHD), behavioral or conduct disorders, anxiety, depression and autism are the most common mental health conditions seen in these patients. Pharmacologic treatment can be complicated, medications are not curative and many psychotropic medications carry significant adverse effect profiles. This session will review efficacy and safety information for some of the most commonly utilized psychotropic medications in adolescent patients, and provide guidance on how to optimize a pharmacist’s role in caring for these patients.
ACPE #0129-0000-18-017-L01-P
APPLICATION-BASED ACTIVITY

OPIOID CRISIS: HOW TO USE GENERATIONRX TO HELP
Justin Friesner, R.Ph., PharmD, Pharmacy Business Specialist, The Kroger Company
GenerationRx has a series of tools that pharmacists can use to educate the public about opioids. This session will review the various presentations and other tools that let YOU make a positive impact on the Ohio opioid crisis. You will experience an overview of the program, and hear how pharmacists are making an impact on this critical problem in our communities.
ACPE #0129-0000-18-018-L04-P
Supported by the OPA Opiate Task Force

9:55 a.m. (CPE Credit/Program: 0.15 CEU)

WHAT’S GOING DOWN WITH HYPERTENSION?!
(repeated at 1:00 p.m.)
Vincent F. Mauro, R.Ph., PharmD, FCCP, Professor of Clinical Pharmacy, UT
This session will discuss the clinical and pharmacotherapeutic implications related to the 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure. Case studies will be utilized to emphasize important pharmacotherapeutic perspectives.
ACPE #0129-0000-18-019-L01-P
APPLICATION-BASED ACTIVITY

2018 OTC AND SELF-CARE CHALLENGE
Moderators: Brigid Groves, R.Ph., PharmD, MS, Pharmacist Care Services Coordinator, Kroger; and Justin Brown, R.Ph., PharmD, Staff Pharmacist, WalMart
Learn up-to-date information about nonprescription products, along with the rationale for product choices, at OPA’s 12th annual “OTC and Self-Care Challenge – Battle of the Colleges!” Join us for a highly interactive, fun-filled session that will enhance your OTC expertise and update your knowledge of common self-care conditions.
ACPE #0129-0000-18-020-L01-P
Supported by NASPA, AACP and the Non-prescription Medicines Academy

ADDRESSING INSOMNIA IN THE COMMUNITY PHARMACY SETTING
Leandro A. Llambí, PharmD, Pharmacy Manager and Patient Care Pharmacist, Kroger Pharmacy
From the Buddha to the American military, many consider sleep to be one of the three pillars of health, along with exercise and nutrition. Unfortunately, in our modern, 24-hour society, sleep is oftentimes considered a luxury, and neglected. This program will prepare the community pharmacist to identify patients suffering from poor sleep, and provide both pharmacotherapeutic and non-pharmacological means of treating insomnia.
ACPE #0129-0000-18-021-L01-P
APPLICATION-BASED ACTIVITY

DOES THE CFO HAVE A DRUG PROBLEM?
Scott McGohan, Chief Executive Officer, McGohan Brabender
Pharmacists are well aware of the pressures and challenges that impact their practices, but are you aware of the bigger picture? With over 70% of employers being self-insured, a CFO’s newly formed role includes the impact on prescription drug cost control today and into the future. Our speaker is an industry leader in helping employers acknowledge, recognize and rein in these costs. Pharmacists have a tremendous opportunity to provide solutions, and to evolve their practice models along the way. This session will provide insight on what employers are looking for, and more importantly, how pharmacists can help address those glaring needs.
ACPE #0129-0000-18-022-L04-P

1:00 p.m. (CPE Credit/Program: 0.15 CEU)

WHAT’S GOING DOWN WITH HYPERTENSION?!
(repeat of 9:55 a.m. program)

OHIO RESEARCH FORUM 2018
Moderator: Timothy R. Ulbrich, PharmD, Associate Dean, Workforce Development and Practice Advancement, NEOMED
Research conducted by Ohio pharmacists, college faculty, pharmacy residents and/or students will be showcased in the annual Ohio Research Forum. Research areas may include those from pharmacy practice, scientific research, economic/social/administrative sciences, and pharmacy education. Following this Podium Session, the Poster Session will open at 4:10 p.m. inside the Exhibit Hall.
ACPE #0129-0000-18-023-L04-P

BILLING CLINICAL SERVICES IN THE OUTPATIENT SETTING
Michael J. Rush, PharmD, BCACP, CDE, TTS, Assistant Clinical Professor of Pharmacy Practice, ONU; and Chuck Riepenhoff, R.Ph., CDE, Clinical Pharmacist, ProMedica Pharmacy Counter
The pharmacist’s role in the ambulatory care setting is expanding, yet receiving reimbursement for services provided remains a challenge. In this session, our speakers will discuss current and emerging options for billing clinical pharmacy services in the outpatient setting.
ACPE #0129-0000-18-024-L04-P

PHARMACY WORKFORCE TRENDS
Donald L. Bennett, R.Ph., MBA, Clinical Assistant Professor, OSU
With the increased number of new pharmacists entering practice annually, the overall supply of pharmacists has increased significantly over the last 10 years. Automation, other technology changes, and expanded roles for pharmacy technicians continue to impact the medication dispensing system. Expanded roles for pharmacists continue to evolve including immunizations, MTM, disease management, and transitions of care. This presentation will focus on the supply and demand of the pharmacy workforce and look at potential expanded roles for pharmacists in the changing healthcare system.
ACPE #0129-0000-18-025-L04-P

SUDDENLY IN-CHARGE: HOW TO BE AN EFFECTIVE YOUNG PHARMACY LEADER IN THE WORKPLACE
Moderator: Jennifer Sabatino, PharmD, R.Ph., BCACP, Clinical Pharmacist at OSU General Internal Medicine; and Panel of NPX Practitioners
A panel of pharmacists will share their experiences being called to leadership positions as new practitioners early in their careers. They will share the challenges they are facing as young leaders in the profession and how they are working to overcome these challenges. Panelists will offer advice on how to prepare for one’s call to leadership, as well as resources to utilize along the way.
ACPE #0129-0000-18-026-L04-P

2:40 p.m. (CPE Credit/Program: 0.15 CEU)

OHIO INNOVATIVE PRACTICE FORUM 2018
Moderators: Jennifer Rodis, PharmD, BCPS, Assistant Dean for Outreach and Engagement, OSU; Timothy R. Ulbrich, PharmD, Associate Dean, Workforce Development and Practice Advancement, NEOMED
Innovative pharmacy practices and services in Ohio will be showcased to help pharmacists initiate or expand novel services and approaches in their own practices. Practitioners from a variety of practice sites will present examples, and share successful implementation strategies and methods for overcoming barriers to offer patient-centered services.
ACPE #0129-0000-18-027-L04-P
Hosted by OPA’s Center for Entrepreneurship

UNRELENTING, UNCONTROLLED, AND UNACCEPTABLE – HOW TO UNDO MIGRAINE HEADACHE PAIN
Mary C. Borovicka, PharmD, BCPS, BCPP, Associate Professor, UT; and Clinical Pharmacist - Psychiatry, MetroHealth Medical Center, Cleveland
This interactive presentation will focus on the treatment of acute migraine and the prevention of migraine headaches. The discussion will include choosing appropriate therapies when potentially interacting drugs or comorbidities are present. Lastly, there will be a discussion of the management of medication overuse headaches and chronic migraine.
ACPE #0129-0000-18-028-L01-P
APPLICATION-BASED ACTIVITY

MEDICAL MARIJUANA - SORTING THROUGH THE HAZE
Justin Kullgren, PharmD, CPE, Palliative Medicine Clinical Pharmacy Specialist, OSU Wexner Medical Center
Starting in September 2018, medical marijuana will be available to be used by qualifying patients in Ohio. It is important for pharmacists to know basic pharmacology about medical marijuana to be able to answer questions that may come from patients or recommenders. This session will aim to provide pharmacists with an update on medical marijuana laws affecting the profession, as well as provide a foundation of clinical knowledge regarding medical marijuana.
ACPE #0129-0000-18-029-L01-P

BEING HUMAN: MEDICATION ERRORS AND THE HUMAN IN THE MIDDLE
Mark Thomas, M.S., R.Ph., Chief Pharmacy Director and Medication Safety Officer, Cincinnati Children’s Hospital Medical Center
This session will explore the variety of ways that human beings perform tasks and how this relates to medication errors and will include useful tools that create an environment in which human errors can be detected and prevented. The session will conclude with a discussion of current medication safety issues.
This program qualifies for State of Ohio Board of Pharmacy patient/medication safety CPE credit.
ACPE #0129-0000-18-030-L05-P

 

SATURDAY, April 21

8:15 a.m. (CPE Credit/Program: 0.15 CEU)

PHARMACY LAW UPDATE, SPRING 2018
(repeated at 9:55 a.m.)
Sheri Zapadka, R.Ph., Compliance Specialist; State of Ohio Board of Pharmacy
Our speaker will present information regarding recent changes to Ohio Laws/Rules, and will review commonly asked questions about opiate prescriptions, protocols, consult agreements, immunizations, technician registration and more. This session is a must for all pharmacists who want to stay up-to-date on legislative and regulatory changes impacting the practice of pharmacy.
This program qualifies for State of Ohio Board of Pharmacy Jurisprudence CPE Credit.
ACPE #0129-0000-18-031-L03-P

DON’T BE AN AUDIT TARGET IN 2018
Mark Jacobs, R.Ph., FASCP, Vice President of Operations, PAAS National ®
Pharmacy auditors are upping their game, and your pharmacy is a target. All too many pharmacies are losing hard earned money on legitimate prescriptions and the number of audits is on the rise. This program centers around plan requirements and strategies to avoid payment recovery on your prescriptions. At the end of this program, participants will be able to describe what pharmacy auditors look for and formulate a plan to avoid costly recoveries.
ACPE #0129-0000-18-032-L04-P

ADVANCES IN DIABETES MANAGEMENT: AN UPDATE ON INSULIN PUMPS, INNOVATIVE TECHNOLOGY AND NEWER THERAPIES
Christopher D. Westrick, PharmD, BCACP, CDE, Specialty Practice Pharmacist, OSU Wexner Medical Center Department of Family Medicine and OSU College of Nursing Total Health and Wellness Clinic
Diabetes continues to be a growing concern within the United States. As a complex, multi-faceted condition, the management of diabetes can be very challenging. This session will discuss advantages and disadvantages of insulin pump therapy including differences in available pumps; review newer technologies with injection devices and glucometers; and lastly, provide a brief look at what is on the horizon. Our speaker, who uses his personal story with diabetes to connect with his patients, will share firsthand experience as a pharmacist and as a patient.
ACPE #0129-0000-18-033-L01-P

UTILIZING PBMS TO IMPLEMENT INNOVATION IN THE COMMUNITY PHARMACY: A PANEL DISCUSSION
Moderator: Marc A. Sweeney, PharmD, Dean, Cedarville
Pharmacy Benefit Managers (PBMs) have been the subject of significant debate within the pharmacy community. Although some PBM models have brought challenges to community pharmacists, several models exist that benefit the community pharmacist. A panel of individuals who are involved with these types of models will discuss their experience.
ACPE #0129-0000-18-034-L04-P

9:55 a.m. (CPE Credit/Program: 0.15 CEU)

PHARMACY LAW UPDATE, SPRING 2018
(repeat of 8:15 a.m. program)

HEPATITIS C TREATMENT UPDATES
Arpi H. Roach, PharmD, CDE, Clinical Pharmacy Specialist, Chalmers P. Wylie VA Ambulatory Clinic, Columbus
Treatment of Hepatitis C has improved dramatically since the virus was discovered in 1989. In the last seven years, 12 new oral direct acting antiviral agents were approved by FDA, and these agents have improved cure rates from 40-50% to over 90-98% with fewer side effects and shorter durations of therapy. This session will explore how pharmacists can play a vital role in the treatment of Hepatitis C by choosing appropriate therapy, duration of therapy, providing education, encouraging adherence, and monitoring for side effects.
ACPE #0129-0000-18-035-L01-P
APPLICATION-BASED ACTIVITY

OTC/SELF-CARE UPDATE: NEW PRODUCTS, NEW LITERATURE, NEW CASES
Daniel L. Krinsky, M.S., R.Ph., Associate Professor, Department of Pharmacy Practice, NEOMED
This session will provide a review of new products that have recently been approved, new formulations, and new literature pertaining to OTC products (NSAIDs, PPIs, sleep meds, and others). Participants will have the opportunity to apply some of this new information, along with current knowledge, to selected case studies.
ACPE #0129-0000-18-036-L01-P
APPLICATION-BASED ACTIVITY

IMPLEMENTING JUST CULTURE IN THE PHARMACY
Amber D. Hartman, PharmD, Medication Safety Pharmacist, OSU Wexner Medical Center
Making an error in the pharmacy can be devastating for the staff involved. Peer and management support utilizing Just Culture principles improves employee satisfaction and patient safety. This presentation will introduce the concepts integral to a Just Culture, demonstrate utilization of the Just Culture algorithm, and provide evidence for the benefits of a just response to errors in the pharmacy.
This program qualifies for State of Ohio Board of Pharmacy patient/medication safety CPE credit.
ACPE #0129-0000-18-037-L05-P
APPLICATION-BASED ACTIVITY

1:30 p.m. (CPE Credit/Program: 0.15 CEU)

INNOVATIVE PHARMACY BUSINESS PLAN COMPETITION 2018
In this annual competition, students have been invited to submit business plans detailing the loan request, mission statement, detailed description of the business, marketing plan and financial reports for buying a pharmacy or developing innovative pharmacy services. Three finalist teams will present their plans to a panel of judges. Hear what the students envision for the future of pharmacy and you may even get ideas for your own practice.
ACPE #0129-0000-18-038-L04-P
Sponsored by Cardinal Health

DEVELOPMENT OF A MEDICATION THERAPY/CHRONIC DISEASE MANAGEMENT CLINIC IN A SMALL COMMUNITY HOSPITAL TO OPTIMIZE CLINICAL OUTCOMES AND REDUCE HOSPITAL READMISSION RATES
Britt A. Cummins, M.S., R.Ph., Director of Pharmacy, Memorial Hospital, Marysville, OH
Improving patient outcomes is a primary goal for healthcare providers. This session will look at a medication therapy/disease management model designed to provide a comprehensive approach to medication therapy and chronic disease management through a combination of transition of care and long term longitudinal strategies. Use of a clinical pharmacist-midlevel provider staffing model to provide transition of care and chronic medication/disease management services will be discussed, as well as the financial and clinical outcome measures utilized to evaluate the effectiveness of these outpatient services.
ACPE #0129-0000-18-039-L04-P

PHARMACIST IMPLEMENTATION OF AN OPIOID ANTAGONIST ADDICTION TREATMENT CLINIC IN AN OUTPATIENT SETTING
Emily Blaiklock, PharmD, Specialty Pharmacist, St. Matthews Community Pharmacy, Louisville, KY
During this session participants will learn about the agent(s) currently available for addiction treatment, with a focus on opioid antagonists and the benefits and barriers these treatment options provide. Implementation of an opioid antagonist addiction treatment clinic will be discussed including the training, liability paperwork, appointment documentation and reimbursement. Barriers to opening and operating a pharmacist run addiction clinic will be presented as well as barriers to patient access and the role of a pharmacist in the addiction treatment
continuum.
ACPE #0129-0000-18-040-L01-P

FUNCTIONAL MEDICINE: IT ALL STARTS IN THE GUT!
Melody L. Hartzler, PharmD, AE-C, BCACP, BC-ADM, Associate Professor, Cedarville and Clinical Pharmacist, Western Medicine Family Physicians, Fairborn, Ohio; and Lauren Castle, PharmD, Market Health and Wellness Director, Walmart Stores Inc. and Founder, Functional Medicine Pharmacists Alliance
This presentation is a follow up to last year’s Functional Medicine: A Primer for Pharmacists. Our speakers will discuss the importance of the gut microbiome on health, explore a functional medicine approach to four prevalent GI disorders (GERD, SIBO, IBS, IBD), and provide integrative treatment options.
ACPE #0129-0000-18-041-L01-P

KIDS GET ARTHRITIS TOO, DON’T LET IT BANKRUPT YOU
Kelly Wise, PharmD, BCACP; Kasandra Chambers, PharmD, MBA; and Megan McNicol, PharmD; Nationwide Children’s Hospital, Columbus
This session will focus on the presentation, classification, and management of juvenile idiopathic arthritis (JIA). Biologic therapies are considered standard of care for patients with high disease activity, but barriers to obtaining biologics include the need for prior authorization, high copayments, and coordinating specialty pharmacies. Our speakers will also dive into the specialty pharmacy environment and the role of a pharmacist in a specialty clinic.
ACPE #0129-0000-18-042-L01-P
3:10 p.m. (CPE Credit/Program: 0.15 CEU)

CLINICAL CASE STUDIES FROM AN OUTPATIENT MEDICATION THERAPY/CHRONIC DISEASE MANAGEMENT CLINIC BASED IN A SMALL COMMUNITY HOSPITAL SETTING
Craig Baker, PharmD, Clinical Pharmacist, Medication Therapies Clinic, Memorial Hospital, Marysville, OH
This session will look at common patient clinical and medication issues that occur during transitions of care between hospital to home and hospital to other healthcare facilities, as well as opportunities for pharmacists to optimize care and clinical outcomes during care transitions. Our speaker will explain how a pharmacist-midlevel provider model can be used for heart failure or COPD clinics to improve transitions of care, reduce hospital readmission rates, and optimize medication management, lifestyle challenges and patient clinical outcomes. Clinical and financial outcomes from a pharmacist-midlevel provider based chronic disease management clinic will be included.
ACPE #0129-0000-18-043-L01-P

HOW TO SAY NO: RATIONAL DISCONTINUATION OF OPIOID ANALGESICS
Phyllis Grauer, R.Ph., PharmD, BCGP, CPE, Palliative Care, Pain and Substance Abuse Clinical Consultant
Rules and guidelines to address the opioid epidemic and reduce inappropriate and excessive prescribing of opioid analgesics have begun to impact numbers of prescriptions, quantities, and amount per dose of these medications. However, too frequently, patients are abruptly cut off from receiving additional opioid prescriptions. When opioids are no longer appropriate, rational discontinuation techniques are necessary along with alternative methods of controlling pain to prevent physical and psychological opioid withdrawal and the potential for driving patients toward illicit methods for managing their suffering.
ACPE #0129-0000-18-044-L01-P

EXPANDING PHARMACY SERVICES TO IMPROVE PUBLIC HEALTH
Natalie DiPietro Mager, PharmD, MPH, Associate Professor of Pharmacy Practice, ONU
Ohio ranks in the bottom quartile among states in regards to health. This session will highlight specific ways in which pharmacists can improve public health in Ohio. Strategies, such as a guide published by the Centers for Disease Control and Prevention and the U.S. Preventive Services Task Force, will be disseminated and participants will use these tools to develop ideas for new pharmacy services to address their community needs.
ACPE #0129-0000-18-045-L04-P

PATIENT-CENTERED MEDICAL HOME MODEL OF CARE: EXPANDING PHARMACY SERVICES
Michelle Cudnik, PharmD, BCACP, Clinical Lead Pharmacist, Ambulatory Care and PGY2 Ambulatory Care Residency Program Director, Summa Health
Pharmacists are expanding patient care services and chronic disease management to improve patient outcomes. Our speaker will discuss Layered Learning and how this can help with expansion of pharmacy services, population health and quality metrics that can help to “sell” the pharmacy service, as well as key stakeholders who need to be at the table for pharmacy service buy in.
ACPE #0129-0000-18-046-L04-P

 

SUNDAY, April 22

8:15 a.m. (CPE Credit/Program: 0.15 CEU)

NEW DRUG UPDATE 2018
(repeated at 9:55 a.m.)
Karen L. Kier, PhD, M.Sc., R.Ph., Professor of Clinical Pharmacy, Director of Assessment, Director of Drug and Health Information, ONU
New drug products that impact current therapy guidelines or are innovative approaches to current treatment are continually released to the market. This program will review the pharmacology and therapeutics of the prescription medications released in the past year, their indications, clinical applications, drug interactions, adverse effects and toxicities, and important patient counseling information.
ACPE #0129-0000-18-047-L01-P

LEGISLATIVE UPDATE 2018
Ernest Boyd, PharmD (Hon), CAE, and Antonio Ciaccia, OPA Lobbyists
The profession of pharmacy is in the midst of a rapid period of change: drug pricing reform, reimbursement pressure, scope of practice advancements, and many regulatory modifications. 2018 is already shaping up to be another big year in this regard. This session will review recent legislative and regulatory changes from the previous year, and provide an essential update on the progress of pending and future advocacy initiatives, including epinephrine accessibility, Medicaid reimbursement, provider status, PBM clawbacks, and much more. Come see what OPA is working on, and become part of the advocacy process.
ACPE #0129-0000-18-048-L04-P

9:55 a.m. (CPE Credit/Program: 0.15 CEU)

NEW DRUG UPDATE 2018
(repeat of 8:15 a.m. program)

ETHICS IN PHARMACY PRACTICE: CASE STUDY DEBATES 2018
Dennis M. Sullivan, MD, MA (Ethics), Director, Center for Bioethics, and Professor of Pharmacy Practice; and Student Panel, Cedarville
The current opioid crisis has stretched emergency and healthcare resources to the limit. Should public policy limit the use of naloxone by first responders for addicts who repeatedly overdose? Also, in light of the movement by states to permit medical use of marijuana, should the DEA change marijuana from schedule I to schedule III? This session will provide an overview of these ethically controversial issues. Four pharmacy students will debate the two topics, with an opportunity for audience interaction.
ACPE #0129-0000-18-049-L04-P

MOTIVATIONAL INTERVIEWING TO ENHANCE PHARMACY PATIENT OUTCOMES
Russell E. Spieth, PhD, CRC, Senior Consultant/Trainer in Motivational Interviewing
Department of Psychiatry, NEOMED; and Jaclyn Boyle, PharmD, MS, MBA, BCACP, BCPS, Assistant Professor for Community Pharmacy Innovation, NEOMED
In this workshop, participants will learn the basic concepts related to using Motivational Interviewing to improve patient outcomes in pharmacy settings. Special attention will be paid to naming, describing and practicing the skills of Motivational Interviewing, such as: open-ended questioning, affirming, reflective listening, summarizing, and informing. Participants will also learn strategies to elicit patient motivational statements and mitigate patient non-motivational statements.
ACPE #0129-0000-18-050-L04-P
APPLICATION-BASED ACTIVITY

11:35 a.m. (CPE Credit/Program: 0.1 CEU)

SELECTING COMPONENTS FOR COMPOUNDING
Richard Dilzer, R.Ph., FACA, FIACP, Director, Pharmacy Technical Services, Spectrum
Pharmacy Products
This program outlines the USP General Chapters for compounding that set the standards for proper selection of components. Our speaker will provide a review of commonly reported values found in a certificate of analysis, necessary for review prior to compounding, along with calculations required for accurately preparing a compounded formulation. The importance of proper documentation of component quality and conformance will also be discussed.
ACPE #0129-0000-18-051-L07-P

IMMUNIZATION UPDATE 2018
Donald L. Bennett, R.Ph., MBA, Clinical Assistant Professor, OSU
This presentation will review the CDC’s Advisory Committee on Immunization Practices updated schedules for adults, adolescents, and children. In addition, new vaccines and expanded recommendations for existing vaccines have occurred during the past year. The vaccination rates and overall impact of the 2017-2018 influenza season will be reviewed.
ACPE #0129-0000-18-052-L06-P

Printer-Friendly Version